Log In
BCIQ
Print this Print this
 

SB-525

  Manage Alerts
Collapse Summary General Information
Company Sangamo BioSciences Inc.
DescriptionAdeno-associated virus (AAV) cDNA human Factor VIII (hFVIII) construct
Molecular Target Factor VIII
Mechanism of Action 
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPreclinical
Standard IndicationHemophilia
Indication DetailsTreat hemophilia A
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today